Correlation Between Marfrig Global and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Marfrig Global and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marfrig Global and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marfrig Global Foods and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Marfrig Global and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marfrig Global with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marfrig Global and Regeneron Pharmaceuticals.
Diversification Opportunities for Marfrig Global and Regeneron Pharmaceuticals
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Marfrig and Regeneron is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Marfrig Global Foods and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Marfrig Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marfrig Global Foods are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Marfrig Global i.e., Marfrig Global and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Marfrig Global and Regeneron Pharmaceuticals
Assuming the 90 days horizon Marfrig Global Foods is expected to generate 2.28 times more return on investment than Regeneron Pharmaceuticals. However, Marfrig Global is 2.28 times more volatile than Regeneron Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 225.00 in Marfrig Global Foods on October 10, 2024 and sell it today you would earn a total of 36.00 from holding Marfrig Global Foods or generate 16.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Marfrig Global Foods vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Marfrig Global Foods |
Regeneron Pharmaceuticals |
Marfrig Global and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Marfrig Global and Regeneron Pharmaceuticals
The main advantage of trading using opposite Marfrig Global and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marfrig Global position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Marfrig Global vs. BRF SA ADR | Marfrig Global vs. Pilgrims Pride Corp | Marfrig Global vs. John B Sanfilippo | Marfrig Global vs. Seneca Foods Corp |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |